-+ 0.00%
-+ 0.00%
-+ 0.00%

Baiyunshan (600332.SH) Branch's cephalexin capsules obtained the Macau Proprietary Drug Registration Certificate

Zhitongcaijing·07/20/2026 08:25:04
Listen to the news

Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, the company's branch Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical General Factory (“Baiyunshan Pharmaceutical General Factory”) received the “Registration Certificate” for cephalexin capsules issued by the Macao Special Administrative Region Government Drug Administration.

According to reports, Baiyunshan Pharmaceutical General Factory submitted a 0.125g drug registration application for cephalexin capsules to the Macao Special Administrative Region Government Drug Administration on June 1, 2026, which was pre-approved on June 22, 2026. Cephalexin capsules are suitable for acute tonsillitis, angina, otitis media, sinusitis, bronchitis, pneumonia and other respiratory infections, urinary tract infections, and skin and soft tissue infections caused by sensitive bacteria. This medicine is an oral preparation and should not be used for severe infections.